Passage Bio, Inc. (PASG)
4.44
+0.01
(+0.23%)
USD |
NASDAQ |
Sep 01, 16:00
4.43
-0.01
(-0.23%)
After-Hours: 20:00
Passage Bio Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 4.606M |
| December 31, 2025 | 20.44M |
| September 30, 2025 | 20.80M |
| June 30, 2025 | 21.14M |
| March 31, 2025 | 21.48M |
| December 31, 2024 | 21.79M |
| September 30, 2024 | 22.08M |
| June 30, 2024 | 22.45M |
| March 31, 2024 | 22.81M |
| December 31, 2023 | 22.92M |
| September 30, 2023 | 23.17M |
| June 30, 2023 | 23.41M |
| March 31, 2023 | 23.65M |
| December 31, 2022 | 23.83M |
| September 30, 2022 | 24.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 24.24M |
| March 31, 2022 | 24.43M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 96.68M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |